CS logo
small CS logo
Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia

A Coruna, LA Coruña, Spain
Maternity hospital in Spain
As, Xubias de Abaixo, s/n, 15009 A Coruña

About Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
24
EMD Serono Research & Development Institute, Inc.
1
Genentech, Inc.
1
Merck KGaA, Darmstadt, Germany
1
Total Rows: 4

Clinical Trials at Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia


During the past decade, Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1122221166442200551111113300Started TrialsCompleted Trails201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
2012-02-17
2019-11-14
Completed
258
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
2012-07-13
2019-09-27
Completed
95
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy
2014-03-11
2019-01-09
Completed
1,225

Rows per page:

1–27 of 27

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 24Hoffmann-La Roche: 24EMD Serono Research &Development Institute,Inc.: 1EMD Serono Research &Development Institute,Inc.: 1Genentech, Inc.: 1Genentech, Inc.: 1Merck KGaA,Darmstadt, Germany: 1Merck KGaA,Darmstadt, Germany: 1

Created with Highcharts 11.1.0Top CollaboratorsGenentech, Inc.: 2Genentech, Inc.: 2Breast International Group: 1Breast International Group: 1Exelixis: 1Exelixis: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1Jazz Pharmaceuticals: 1Jazz Pharmaceuticals: 1Merck KGaA,Darmstadt, Germany: 1Merck KGaA,Darmstadt, Germany: 1

Clinical Trials Conditions at Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia


According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia" are "Breast Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Metastatic Breast Cancer" (2 trials), "Non-small Cell Lung Cancer (NSCLC)" (2 trials) and "Triple-Negative Breast Cancer" (2 trials). Many other conditions were trialed in "Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia" in a lesser frequency.

Clinical Trials Intervention Types at Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia


Most popular intervention types in "Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia" are "Drug" (27 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (13 trials), "Carboplatin" (7 trials), "Docetaxel" (5 trials), "Placebo" (5 trials) and "Tiragolumab" (5 trials). Other intervention names were less common.

Clinical Trials Genders at Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia


The vast majority of trials in "Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia" are 25 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia


Currently, there are NaN active trials in "Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 19Phase 3: 19Phase 2: 7Phase 2: 7Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 12Completed: 12Recruiting: 8Recruiting: 8Active, not recruiting: 7Active, not recruiting: 7